IO Biotech (IOBT) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free IOBT Stock Alerts $1.47 +0.03 (+2.08%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIO Biotech (IOBT) Price Target Decreased by 11.11% to 8.16msn.com - April 17 at 10:15 AMIO Biotech, Inc. (NASDAQ:IOBT) Sees Large Decline in Short Interestamericanbankingnews.com - April 16 at 4:22 AMIO Biotech Expands Senior Leadership Team to Progress Commercialization Readinessglobenewswire.com - April 15 at 8:30 AMIO Biotech presents cancer vaccine data at AACRinvesting.com - April 11 at 12:59 AMIO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103globenewswire.com - April 9 at 12:00 PMIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officerglobenewswire.com - April 5 at 8:30 AMIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Up 50.3% in Marchmarketbeat.com - March 29 at 9:42 PMShort Interest in IO Biotech, Inc. (NASDAQ:IOBT) Rises By 10.4%marketbeat.com - March 18 at 5:14 PMAnalysts Offer Predictions for IO Biotech, Inc.'s Q1 2024 Earnings (NASDAQ:IOBT)marketbeat.com - March 11 at 1:48 AMIO Biotech Inc (IOBT) Reports Year-End Financial Results and Progress in Clinical Trialsfinance.yahoo.com - March 7 at 3:57 PMBuy Recommendation for IO Biotech on Strong Data Prospects and Undervalued Stock Positionmarkets.businessinsider.com - March 6 at 11:14 PMIO Biotech Inc IOBTmorningstar.com - March 6 at 6:14 PMIO Biotech GAAP EPS of -$0.40 misses by $0.02msn.com - March 6 at 6:14 PMIO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meetingglobenewswire.com - March 6 at 4:11 PMIO Biotech (NASDAQ:IOBT) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - March 6 at 8:45 AMIOBT Stock Earnings: IO Biotech Misses EPS for Q4 2023investorplace.com - March 5 at 11:33 PMIO Biotech Announces 2023 Fourth-Quarter and Year-End Resultsglobenewswire.com - March 5 at 4:40 PMArmistice Capital LLC Buys New Shares in IO Biotech, Inc. (NASDAQ:IOBT)marketbeat.com - March 3 at 10:51 AMIO Biotech to Present at 44th Annual Cowen Health Care Conferenceglobenewswire.com - February 26 at 4:05 PMIO Biotech, Inc. (NASDAQ:IOBT) Sees Significant Drop in Short Interestmarketbeat.com - February 15 at 8:53 AMVivo Capital LLC Has $8.71 Million Stake in IO Biotech, Inc. (NASDAQ:IOBT)marketbeat.com - February 6 at 1:40 PMWhat's Next for Iovance Biotherapeutics Stock?msn.com - February 4 at 7:42 AMIO Biotech, Inc. (NASDAQ:IOBT) most popular amongst private equity firms who own 61% of the shares, institutions hold 24%finance.yahoo.com - January 15 at 7:53 AMIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Updatemarketbeat.com - January 3 at 4:00 PMIO Biotech: A Phase 3 Company Getting No Respectseekingalpha.com - January 3 at 9:34 AMIO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trialfinance.yahoo.com - December 21 at 8:45 AMWe're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn Ratefinance.yahoo.com - December 19 at 7:40 AMIO Biotech executive discloses purchase of 10K sharesmsn.com - November 27 at 7:14 PMIOBT IO Biotech, Inc.seekingalpha.com - November 24 at 7:32 PMIO Biotech earnings beat, revenue was in line with estimatesinvesting.com - November 15 at 8:26 PMPromising Clinical Trials and Favorable Safety Profile Drives Buy Rating for IO Biotechmarkets.businessinsider.com - November 15 at 10:25 AMIO Biotech Stock (NASDAQ:IOBT) Earnings Dates and Earning Callsbenzinga.com - November 14 at 6:32 PMIO Biotech GAAP EPS of -$0.43 misses by $0.10msn.com - November 13 at 3:06 PMIO Biotech: Q3 Earnings Insightsbenzinga.com - November 13 at 10:05 AMIO Biotech Announces 2023 Third Quarter Resultsfinance.yahoo.com - November 13 at 10:05 AMIO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanomafinance.yahoo.com - November 10 at 8:53 AMThis IO Biotech Insider Increased Their Holding In The Last Yearfinance.yahoo.com - November 7 at 9:52 AMIO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meetingtmcnet.com - November 1 at 2:32 PMIO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meetingfinance.yahoo.com - November 1 at 9:32 AMEncouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Society for Medical Oncology (ESMO) Congressfinance.yahoo.com - October 23 at 6:38 AMIO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meetingfinance.yahoo.com - October 3 at 8:39 PMPiper Sandler Initiates Coverage of IO Biotech (IOBT) with Overweight Recommendationnasdaq.com - September 28 at 11:37 PMExpert Ratings for IO Biotechmarkets.businessinsider.com - September 28 at 1:37 PMIO Biotech’s Immunotherapy Approach and Undervalued Market Position: A High Reward Potential Stockmarkets.businessinsider.com - September 28 at 8:37 AMH.C. Wainwright Remains a Buy on IO Biotech (IOBT)markets.businessinsider.com - September 13 at 7:33 AMIO Biotech Announces New Data Related to its IO102-IO103 Therapeutic Cancer Vaccine Presented Today at the IASLC 2023 World Conference on Lung Cancerfinance.yahoo.com - September 12 at 9:47 AMIO Biotech Announces Participation in Upcoming Investor Conferencesfinance.yahoo.com - September 6 at 8:59 AMStonepine Capital Management, LLC Acquires New Stake in IO Biotech Incfinance.yahoo.com - August 17 at 11:56 AM10 Best New Penny Stocks to Buy Nowfinance.yahoo.com - August 17 at 11:56 AMMorgan Stanley Maintains IO Biotech (IOBT) Overweight Recommendationmsn.com - August 15 at 8:43 PM Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him IOBT Media Mentions By Week IOBT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IOBT News Sentiment▼0.940.45▲Average Medical News Sentiment IOBT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IOBT Articles This Week▼11▲IOBT Articles Average Week Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cartesian Therapeutics News Today Anixa Biosciences News Today Emergent BioSolutions News Today PDS Biotechnology News Today Barinthus Biotherapeutics News Today Oramed Pharmaceuticals News Today Cellectar Biosciences News Today Seres Therapeutics News Today Genelux News Today InterCure News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IOBT) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeHow to camouflage a factory of 53,000 workersStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
